文献速递乳腺外科

新辅助治疗促进可手术乳腺癌保乳的荟萃分析

Meta-analysis of neoadjuvant therapy and its impact in facilitating breast conservation in operable breast cancer.
PubMed 文献 · Br J Surg · 2018-01-01

该系统综述纳入7项RCT共1452例可手术乳腺癌患者,评估新辅助治疗(NAT)后保乳手术(BCS)的实施情况。临床评估符合BCS者中仅31%实际行BCS,达到病理完全缓解的乳房切除候选者中仅41%转为BCS。结论认为NAT后的手术选择未充分反映肿瘤反应,可能导致不必要的根治性手术。

要点

  • 临床评估符合BCS者中仅31%实际接受BCS。
  • 病理完全缓解的乳房切除候选者中仅41%转为BCS。

核心结论

  • NAT后的乳房手术未反映肿瘤反应,可能导致潜在不必要的根治性手术,尤其是乳房切除术。

研究设计与样本

  • 系统综述纳入7项RCT,共1452例可手术乳腺癌患者,纳入标准包括NAT前后手术评估记录、手术方式及临床病理反应。

主要发现

  • 影响未转为BCS的主要因素包括NAT前临床评估、多中心性和初诊肿瘤大小。

临床怎么用

  • NAT后应重新评估手术方式,避免因初始评估等因素忽略肿瘤降期带来的保乳机会。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neoadjuvant therapy (NAT) for operable breast cancer may facilitate more breast-conserving surgery (BCS). It seems, however, that this benefit is not being realized fully. METHODS: A systematic review of the literature was performed. RCTs were included. The criteria for inclusion were: documentation of surgical assessment before and after NAT, surgery performed (BCS or mastectomy), and clinical and pathological responses. RESULTS: A total of 1452 patients from seven RCTs met the inclusion criteria. After NAT, the feasibility of BCS increased from 43·3 to 60·4 per cent (P < 0·001), but BCS was performed in only 51·8 per cent (P = 0·04). Only 31 per cent of patients who became eligible for BCS (assessed on clinical response) underwent BCS (pooled rate ratio 0·31, 95 per cent c.i. 0·22 to 0·44; P < 0·001). Of the mastectomy candidates who achieved a pathological complete response after NAT, only 41 per cent underwent BCS (pooled rate ratio 0·41, 0·23 to 0·74; P = 0·003). The main factors that influenced the decision not to shift to BCS, even though it was feasible, were clinical assessment before NAT, multicentricity and tumour size at presentation. CONCLUSION: Breast surgery performed after NAT does not reflect tumour response, resulting in potentially unnecessary radical surgery, especially mastectomy. The barriers to maximizing the surgical benefits of NAT need to be better understood and explored.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Karakatsanis A, Tasoulis MK, Wärnberg F, et al. Meta-analysis of neoadjuvant therapy and its impact in facilitating breast conservation in operable breast cancer. Br J Surg. 2018. PMID: 29603132. doi:10.1002/bjs.10807

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。